retatrutide triple agonist peptide Retatrutide. The next evolution. A next-generation designed to advance metabolic research through GLP-1, GIP, and glucagon receptor pathways. Supporting innovation through trusted sourcing. For healthcare professionals. Research retatrutide

Based upon self-reported data from approximately 12,000 customers subscribed to a comprehensive Hims & Hers weight loss offering, customers report having lost, on average, 10.2 pounds while on compounded GLP-1 injections and 6.3 pounds while on non-GLP-1 compounded oral medication kits, along with a reduced calorie diet and exercise, between their initial weight at consultation and their first check-in approximately 4 weeks later

When the levels of glutamate, an excitatory neurotransmitter, increase in the brain, or when the levels of GABA, an inhibitory neurotransmitter, decrease, the balance is disrupted

Potential therapeutic effects (based on animal and early human data): Enhances tendon, ligament, and muscle repair Promotes angiogenesis (formation of new blood vessels) Reduces inflammation and oxidative stress Protects gut mucosa and may aid in GI disorders (ulcers, leaky gut) May support neurological recovery and joint health Modulates nitric oxide and dopamine/serotonin pathways (possible mood, focus benefits) (Note: Most data are from preclinical studies

Table 5: Folic Acid Medication Table The table below is not an exhaustive list of all folic acid products and therapeutic considerations